期刊文献+

2型糖尿病患者血清胆红素与尿白蛋白的相关性研究 被引量:10

Relationship between serum bilirubin and urinary albumin in patients with type 2 diabetes
下载PDF
导出
摘要 目的 探讨2型糖尿病患者血清胆红素与尿白蛋白水平之间的相关性.方法 选取2型糖尿病患者686例,根据尿白蛋白排泄率(UAER)水平将其分为正常白蛋白尿组(UAER<20 μg/min,329例)、微量白蛋白尿组(20 μg/min≤UAER< 200 μg/min,297例)和显性白蛋白尿组(UAER≥200 μg/min,60例),比较3组间血清胆红素水平的差异,采用Spearman相关分析和Stepwise多元逐步回归分析评价胆红素对UAER的影响.结果 显性白蛋白尿组患者的总胆红素(TBIL)、直接胆红素(DBIL)和间接胆红素(IBIL)水平[分别是(8.4±3.7)μmol/L、(2.3±1.2)μmol/L和(6.1±3.0) μmol/L]较微量白蛋白尿组[分别是(10.6±4.8) μmol/L、(3.1±1.7)μmol/L和(7.4±3.5) μmol/L]和正常白蛋白尿组[(11.3±6.3)μmol/L、(3.5±2.8) μmol/L和(7.8±4.3) μmol/L]显著降低(P<0.01或P<0.05).TBIL(r=-0.084,P=0.027)、DBIL(r=-0.110,P=0.005)与UAER呈显著负相关.结论胆红素可能是2型糖尿病肾病的保护性因素,应重视胆红素的抗氧化作用. Objective To explore the relationship between serum bilirubin and urinary albumin in patients with type 2 diabetes. Methods 686 patients with type 2 diabetes were divided into three groups based on urine albumin excretion rate (UAER) levels. Serum bilirubin levels of each group were determined. Correlation between bilirubin and UAER was performed using Spearman' s rank correlation and stepwise multiple regression analysis. Results The total bilirubin ( TBIL), direct bilirubin (DBIL) and indirect bi|iruhin(IBIL) levels in macroalbuminuria group were (8.4 ± 3.7 ) μmol/L, (2.3 ± 1.2 ) μmol/L and( 6. l ± 3.0 )μmol/L ,which in microalbuminuria group were (10.6 ± 4.8 )μmol/L, (3.1 ±1.7 ) μmol/L and ( 7.4 ± 3.5 ) μmol/L, which in normal albuminuria group were ( 11.3 ± 6.3 ) μmol/L, ( 3.5 ± 2.8 ) μmol/L and ( 7.8 ± 4.3 ) μmol/L. There were significant differences among these three groups ( P 〈 0.01-0.05 ). TBIL ( r = - O. 084, P = 0. 027 ), DBIL ( r = - 0. 110, P = 0. 005 ) and UAER was a significant negative correlation. Conclusion Bilirubin may be a protective factor for type 2 diabetic nephropathy. The bilirubin antioxidant effects should be taken seriously.
出处 《临床内科杂志》 CAS 2013年第5期323-325,共3页 Journal of Clinical Internal Medicine
基金 上海市卫生局青年基金资助项目(2010Y042) 上海市闵行区科委自然基金资助项目(2010MHZ026)
关键词 胆红素 糖尿病 2型 尿白蛋白 Bilirubin Diabetes mellitus,type 2 Urinary albumin
  • 相关文献

参考文献10

  • 1Choi SW, Lee YH, Kweon SS, et al. Association between total bilirubin and hemoglobin AI c in Korean type 2 diabetic patients. J Korean Med Sci ,2012,27 : 1196-1201.
  • 2Jo J, Yun JE, Lee H, et al. Total, direct, and indirect serum bilirubin concentrations and metabolic syndrome among the Korean population. Endocrine,2011,39 : 182-189,.
  • 3Hart SS, Na KY, Chae DW, et al. High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy. To- hoku J Exp Med,2010,221:133-140.
  • 4Vftek L. The role of bilirubin in diabetes, metabolic syndrome, and car- diovascular diseases. Front Pharmacol ,2012,3 : 55.
  • 5邱宇珍,龙辉.2型糖尿病并非酒精性脂肪性肝病患者炎症反应及氧化应激水平与动脉硬化的关系[J].临床内科杂志,2013,30(2):89-91. 被引量:4
  • 6王瑞良,张洪梅,苏青.糖脉康颗粒对糖尿病大鼠肾组织氧化应激及羰基应激的影响.中国医师杂志,2011,z2:7-10.
  • 7Lanone S, Bloc S, Foresti R, et al. Bilirubin decreases NOS2 expression via inhibition of NAD (P) H oxidase : implications for protection against endotoxic shock in rats. FASEB J,2005,19 : 1890-1892.
  • 8Baranano DE, Rao M, Ferris CO, et al. Biliverdin reductase : A major physiologic cytoprotectant. Proc Natl Acad Sci ,2002,99:16093-16098.
  • 9Sedlak TW, Snyder SH. Bilirubin benefits:cellular protection by a bili- verdin reductase antioxidant cycle. Pediatrlcs,2004,113 : 1776-1782.
  • 10Fukui M ,Tanaka M ,Shiraishi E ,et al. Relationship between serum bili- rubin and albuminuria in patients with type 2 diabetes. Kidney Int, 2008,74 : 1197-1201.

二级参考文献4

共引文献3

同被引文献72

  • 1万静,刘丽梅.氧化应激—抗氧化系统与糖尿病肾病[J].国际内分泌代谢杂志,2006,26(B04):18-20. 被引量:12
  • 2纪立农.2型糖尿病遗传病因学研究的现状和展望[J].中国医学科学院学报,2006,28(2):278-283. 被引量:11
  • 3Blanes JI,Representatives of Spanish Society of Surgeons (ACS),Representatives of Spanish Society of Emergency Medicine(SEMES),et al.Consensus document on treatment of infections in diabetic foot.Rev Esp Quimioter,2011,24:233-262.
  • 4Lerman B,Oldenbrook L,Ryu J,et al.The SNaP Wound Care System:a case series using a novel ultraportable negative pressure wound therapy device for the treatment of diabetic lower extremity wounds.J Diabetes Sci Technol,2010,4:825-830.
  • 5Ramundo J,Gray M.Enzymatic wound debridement.J Wound Ostomy Continence Nurs,2008,35:273-280.
  • 6Huang J, Dai C, Yu M, et al. Abnormal liver function test predicts type 2 diabetes: a community-based prospective study: response to Cho et al [J]. Diabetes care, 2008, 31(6): e53.
  • 7Balkau B, Lange C, Vol S, et al. Nine-year incident diabetes is predicted by fatty liver indices: the French DESIR study[J]. Bmc Gas- troenterology, 2010, 10(56): 1-9.
  • 8Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation[J]. Geneva: World Health Organization, 2006, 21. ISBN 978-92-4-159493-6.
  • 9Oka R, Aizawa T, Yagi K, et al. Elevated liver enzymes arc related to progression to impaired glucose tolerance in Japanese men [J]. Diabetic Medicine, 2014, 31(5): 552-558.
  • 10Auguet T, Terra X, Quintero Y, et al. Liver Lipocalin 2 Expression in Severely Obese Women With Non Alcoholic Faro/Liver Disease[J]. Experimental and Clinical Endocrinology & Diabetes, 2013, 121 (2):119-124.

引证文献10

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部